Marisa Iborra

21PUBLICATIONS
121CO-AUTHORS
Comparative and cross-cultural educationDisease surveillanceApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Immunology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jun 05, 2026
Training satisfaction, competency gaps and well-being in gastroenterology residency in Spain: results of a national SEPD survey.

|Apr 30, 2026
Real-World Effectiveness and Safety of Upadacitinib in Crohn's Disease: Insights From the Eneida Registry.

|Jan 29, 2026
Long-term use of subcutaneous infliximab biosimilar CT-P13 in patients with inflammatory bowel disease in clinical practice.

José María Huguet, Lidia Martí Romero, Marta Maia Boscá-Watts

|Dec 31, 2025
Comparative Efficacy and Immunogenicity of Infliximab and Adalimumab in Crohn's Disease: A Prospective Cohort Study.

Luis G Guijarro, Patricia de Castro-Martínez, María Chaparro

|Nov 27, 2025
Cytokine Dynamics During Ustekinumab Induction as Predictors of Treatment Response in Crohn's Disease: An Observational Study.

Alejandro Mínguez, Beatriz Mateos, Marisa Iborra

|May 03, 2025
Long-Term Outcomes Following Withdrawal of Anti-Tumour Necrosis Factor Treatment in Inflammatory Bowel Disease Patients in Remission: The Exit Long-Term Study of GETECCU.

María José Casanova, Cristina Rubín de Célix, Sabino Riestra

Pageof 4

Frequent Collaborators

9 joint publications

Javier P Gisbert

8 joint publications

Francisco Mesonero

6 joint publications

Iván Guerra

6 joint publications

Eugeni Doménech